These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 568069)
21. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats. Hossain MA; Weiner N J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556 [TBL] [Abstract][Full Text] [Related]
22. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
23. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822. Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023 [TBL] [Abstract][Full Text] [Related]
24. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Huang KX; Bergstrom DA; Ruskin DN; Walters JR Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877 [TBL] [Abstract][Full Text] [Related]
25. Intranigral kainic acid: evidence for nigral non-dopaminergic neurons controlling posture and behavior in a manner opposite to the dopaminergic ones. Olianas MC; De Montis GM; Concu A; Tagliamonte A; di Chiara G Eur J Pharmacol; 1978 Jun; 49(3):223-32. PubMed ID: 566206 [TBL] [Abstract][Full Text] [Related]
26. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra. Satoh H; Satoh Y; Notsu Y; Honda F Eur J Pharmacol; 1976 Oct; 39(2):365-77. PubMed ID: 185065 [TBL] [Abstract][Full Text] [Related]
27. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG; Walters JR Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219 [TBL] [Abstract][Full Text] [Related]
28. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input. Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044 [TBL] [Abstract][Full Text] [Related]
29. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra. Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143 [TBL] [Abstract][Full Text] [Related]
30. Dopaminergic inhibition of anterior pituitary adenylate cyclase activity and prolactin release: the effects of perturbing calcium on catalytic adenylate cyclase activity. Schettini G; Hewlett EL; Cronin MJ; Koike K; Yasumoto T; MacLeod RM Neuroendocrinology; 1986; 44(1):1-7. PubMed ID: 3024052 [TBL] [Abstract][Full Text] [Related]
31. Dopamine-sensitive adenylate cyclase: location in substantia nigra. Gale K; Guidotti A; Costa E Science; 1977 Feb; 195(4277):503-5. PubMed ID: 13499 [TBL] [Abstract][Full Text] [Related]
32. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases. Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225 [TBL] [Abstract][Full Text] [Related]
33. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain. Miller RJ; Kelly PH; Neumeyer JL Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290 [TBL] [Abstract][Full Text] [Related]
35. Dopamine receptor changes in response to prolonged treatment with L-dopa. Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813 [TBL] [Abstract][Full Text] [Related]
36. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK; Manzino L; Heikkila RE J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [TBL] [Abstract][Full Text] [Related]
37. Dopamine receptor sensitivity following nigrostriatal lesion in the aged rat. Hirschhorn ID; Makman MH; Sharpless NS Brain Res; 1982 Feb; 234(2):357-68. PubMed ID: 7199364 [TBL] [Abstract][Full Text] [Related]
38. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons. Carlson JH; Bergstrom DA; Weick BG; Walters JR Synapse; 1987; 1(5):411-6. PubMed ID: 2975067 [TBL] [Abstract][Full Text] [Related]
40. Neurotensin-dopamine interactions in the substantia nigra of the rat brain. Merchant KM; Bush LG; Gibb JW; Hanson GR J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]